COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 2944: Articles 29431-29440  | Next

How many are at increased risk of severe COVID-19 disease? Rapid global, regional and national estimates for 2020
Clark, A., Jit, M., Warren-Gash, C., Guthrie, B., Wang, H. H., Mercer, S. W., Sanderson, C., McKee, M., Troeger, C., Ong, K. I., Checchi, F., Perel, P., Joseph, S., Gibbs, H. P., Banerjee, A., LSHTM CMMID COVID-19 working group, , Eggo, R. M.
10.1101/2020.04.18.20064774 — Posted: 2020-04-22 Discussion: Onsite | Offsite
Controlled Avalanche: A Regulated Voluntary Exposure Approach for Addressing Covid19
Klement, E., Klement, A., Chinitz, D., Harel, A., Fattal, E., Klausner, Z.
10.1101/2020.04.12.20062687 — Posted: 2020-04-22
The Enlightenment of mainland China's epidemic situation to the world through the intrinsic growth rule of infected and cured cases with COVID-19
Han, C., Liu, Y., Tang, J., Zhu, Y., Yang, S.
10.1101/2020.04.16.20067454 — Posted: 2020-04-22
Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy
Carsana, L., Sonzogni, A., Nasr, A., Rossi, R., Pellegrinelli, A., Zerbi, P., Rech, R., Colombo, R., Antinori, S., Corbellino, M., Galli, M., Catena, E., Tosoni, A., Gianatti, A., Nebuloni, M.
10.1101/2020.04.19.20054262 — Posted: 2020-04-22 Discussion: Onsite | Offsite
Interleukin-6 blockade for severe COVID-19
ROUMIER, M., PAULE, R., GROH, M., VALLEE, A., ACKERMANN, F.
10.1101/2020.04.20.20061861 — Posted: 2020-04-22
Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors
Braun, J., Loyal, L., Frentsch, M., Wendisch, D., Georg, P., Kurth, F., Hippenstiel, S., Dingeldey, M., Kruse, B., Fauchere, F., Baysal, E., Mangold, M., Henze, L., Lauster, R., Mall, M., Beyer, K., Roehmel, J., Schmitz, J., Miltenyi, S., Mueller, M. A., Witzenrath, M., Suttorp, N., Kern, F., Reimer, U., Wenschuh, H., Drosten, C., Corman, V. M., Giesecke-Thiel, C., Sander, L.-E., Thiel, A.
10.1101/2020.04.17.20061440 — Posted: 2020-04-22 Discussion: Onsite
COVID-19 diagnosis and study of serum SARS-CoV-2 specific IgA, IgM and IgG by a quantitative and sensitive immunoassay
Ma, H., Zeng, W., He, H., Zhao, D., Yang, Y., Jiang, D., Zhou, P., Qi, Y., He, W., Zhao, C., Yi, R., Wang, X., Wang, B., Xu, Y., Yang, Y., Kombe Kombe, A. J., Ding, C., Xie, J., Gao, Y., Cheng, L., Li, Y., Ma, X., Jin, T.
10.1101/2020.04.17.20064907 — Posted: 2020-04-22 Discussion: Offsite
Effectiveness of Intravenous Immunoglobulin for Children with Severe COVID-19: A Rapid Review
Zhang, J., Yang, Y., Yang, N., Ma, Y., Zhou, Q., Li, W., Wang, X., Huang, L., Luo, X., Fukuoka, T., Ahn, H. S., Lee, M. S., Luo, Z., Chen, Y., Liu, E., Yang, K., Fu, Z.
10.1101/2020.04.17.20064444 — Posted: 2020-04-22
Impact of blood analysis and immune function on the prognosis of patients with COVID-19
Fu, Y.-q., Sun, Y.-l., Lu, S.-w., Yang, Y., Wang, Y., Xu, F.
10.1101/2020.04.16.20067587 — Posted: 2020-04-22
Estimates of COVID-19 case-fatality risk from individual-level data
Bignami, S., Ghio, D., Van Assche, A.
10.1101/2020.04.16.20067751 — Posted: 2020-04-22 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).